Sirtuins: What They Are and Why Activating a Pathway Is Not Longevity

Sirtuins often appear online as a hidden switch: turn it on with fasting, exercise, NAD+ or resveratrol and the body “activates longevity”. The real biology is more interesting and much less obedient.

Sirtuins are seven human enzymes, SIRT1 to SIRT7. They use NAD+ to remove selected chemical modifications from proteins and participate in metabolism, stress responses, DNA repair, inflammation and mitochondrial function. They are pieces in a network, not a master button.

One family, seven members

The shared name can make the seven proteins seem interchangeable. They are not. Even their chemistry varies: besides deacetylation, some remove other protein modifications. This table is a map, not a treatment list.

Protein	Main location	Research areas
SIRT1	Nucleus and cytoplasm	Energy response, inflammation, autophagy and transcription factors
SIRT2	Cytoplasm and nucleus	Cell cycle, cytoskeleton and nervous system
SIRT3	Mitochondrion	Metabolic enzymes, oxidative defence and energy adaptation
SIRT4	Mitochondrion	Nutrient metabolism and cellular signalling
SIRT5	Mitochondrion and other compartments	Deacylation, urea cycle and metabolic balance
SIRT6	Nucleus	Chromatin, DNA repair, metabolism and telomeres
SIRT7	Nucleolus and nucleus	Ribosome production, genomic stability and stress

SIRT3, SIRT4 and SIRT5 are often called mitochondrial sirtuins. To understand the organelle in which they act, our guide to mitochondrial dysfunction and ageing separates energy production, stress signalling and clinical disease.

From Sir2 to “longevity genes”

Excitement began with Sir2, a yeast protein linked to replicative lifespan. Worms, flies and mammals followed, producing important but not uniformly consistent results. Even the idea that sirtuins are “conserved longevity genes” remains debated.

A critical review by Charles Brenner argues that findings across species and human genetics do not form a clean line. This does not make sirtuins irrelevant. It forces a better question: which protein, in which tissue, under which intervention and against which outcome?

In mice, SIRT6 is instructive. A 2012 transgenic study found longer life in males overexpressing SIRT6, but not in females. This is causal evidence within a specific model and also shows that sex and biological context change the result. It does not establish that increasing SIRT6 is feasible, safe or effective in people.

NAD+ is a substrate, not a certificate of activity

Sirtuins consume NAD+ during their reactions. That produces an appealing inference: if more NAD+ lets them work, more must be better. Yet NAD+ also feeds other enzymes, differs between compartments and tissues and is shaped by production, recycling and consumption.

One blood tube cannot summarise that system. In 2026, a seven-cohort human study found remarkably stable whole-blood NAD+ across age and lifestyle interventions. Its method did detect changes after nicotinamide riboside. The conclusion is specific: whole-blood NAD+ is not a useful general biomarker of ageing or lifestyle.

This also limits the phrase “activate sirtuins”. Raising a blood metabolite demonstrates biochemical exposure. Proving SIRT activity would require measuring the enzyme or its targets in the relevant tissue. Proving benefit would additionally require improvement in function, symptoms or clinical events.

What NR and NMN have shown in people

NR and NMN are precursors that the body can use in NAD+ synthesis pathways. A 2025 clinical review captures the field well: increases in NAD+ metabolites are reproducible, while functional and metabolic outcomes are heterogeneous and long-term data remain limited.

Two trials show the distinction:

• In postmenopausal women with prediabetes, an NMN trial reported better muscle insulin sensitivity without matching changes across several systemic outcomes.
• In older men, another NMN trial raised blood NAD+ and explored muscle measures. It was not a longevity trial and did not measure every sirtuin across tissues.

These findings justify more research and perhaps selected uses. They do not show that every adult will benefit or that more NAD+ means rejuvenation. Our NAD+ therapy guide separately reviews oral precursors, intravenous delivery and the clinical-outcome gap.

A 2026 systematic review reached a particularly useful conclusion for IV delivery: oral precursors show biochemical target engagement, but clinical-outcome trials of intravenous NAD+ for anti-ageing or wellness indications are missing. A route of administration cannot fill an evidence gap by itself.

Resveratrol and the sirtfood story

Resveratrol, quercetin, fisetin and catechins affect multiple pathways in experimental models. Calling them “sirtuin activators” as if they were specific keys is too simple. Resveratrol's direct interaction with SIRT1 depends on substrate and assay, while its cellular effects also involve AMPK and other pathways.

A 30-day study in 11 men with obesity found metabolic changes and muscle signals after resveratrol. It was small, brief and did not assess longevity. It does not make wine a therapy either: dietary amounts are low and alcohol brings its own risks.

The “sirtfood diet” is right to highlight plant foods, but their value does not need a story about switched-on genes. Fibre, nutrient density, displacement of ultra-processed foods and the overall dietary pattern sit closer to human evidence.

Exercise, fasting and the one-pathway trap

Exercise and energy restriction alter metabolic state and activate networks that include AMPK, mTOR, autophagy, PGC-1α and sirtuins. Attributing every benefit to SIRT1 or SIRT3 is like explaining an orchestra through one instrument.

Human evidence supports training for cardiorespiratory fitness, strength, insulin sensitivity and cardiovascular health. Fasting or calorie restriction can help selected people, particularly when it improves adherence or energy balance. It does not show that a 16:8 window “switches on longevity genes”. If you are considering it, our therapeutic fasting guide explains who may be harmed and which outcomes matter.

How to read a sirtuin claim

Question	Why it matters
Was NAD+ or one SIRT's activity measured?	A substrate and an enzyme are not the same measurement
In blood, muscle, fat, liver or brain?	Biology is tissue- and compartment-specific
Cell, animal or human trial?	The distance to a recommendation changes greatly
Biomarker or clinical outcome?	A molecular signal does not guarantee function or less disease
Which comparison and how long?	Without a control and sufficient duration, effects can mislead
Which risks and interactions were assessed?	“Natural” and “metabolic” do not mean harmless

The conclusion can be upbeat without becoming grandiose: we have a fascinating enzyme family that helps explain how a cell connects energy with maintenance. Understanding it improves our questions. It still does not provide a human switch for longer life.

Frequently asked questions

What are sirtuins?

They are seven human enzymes, SIRT1 to SIRT7, that use NAD+ to modify proteins and regulate processes such as metabolism, stress response, DNA repair and mitochondrial function.

Why are they called longevity proteins?

The nickname came from experiments in simple organisms and selected animal models. It describes a research field, not proof that activating them extends human life.

Are NAD+ and sirtuins the same thing?

No. NAD+ is a coenzyme involved in many reactions. Sirtuins are enzymes that consume NAD+ as a substrate, alongside other cellular enzyme families that also use it.

Does raising NAD+ activate sirtuins?

It may increase substrate availability, but a rise in blood does not prove that a specific sirtuin is activated in muscle, liver or brain or that a clinical outcome improves.

Can sirtuin activity be measured in a blood test?

There is no routine clinical test that summarises SIRT1 to SIRT7 activity across the body. Expression or activity can be measured in research and depends on tissue.

Does resveratrol activate SIRT1?

Resveratrol affects several pathways, and its direct relationship with SIRT1 depends on method and substrate. Small human studies do not show that it extends life.

Do fasting and exercise work through sirtuins?

Sirtuins participate in some responses to exercise and energy restriction, but they are not the only mechanism. Human benefits should not be attributed to one pathway.

Is there a proven sirtuin supplement?

No supplement has been shown to extend life by activating sirtuins. NR, NMN and polyphenols can change selected metabolites or markers, with variable clinical results.

Sources

1. Brenner C. Sirtuins are not conserved longevity genes. 2022. PMID: 37035412.
2. Kanfi Y et al. The sirtuin SIRT6 regulates lifespan in male mice. 2012. PMID: 22367546.
3. Vinten KT et al. NAD+ precursor supplementation in human ageing. 2025. PMID: 41083806.
4. Trętowicz P et al. Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. 2026.
5. Yoshino M et al. NMN increases muscle insulin sensitivity in prediabetic women. 2021. PMID: 33888596.
6. Igarashi M et al. Chronic NMN supplementation elevates blood NAD+ levels. 2022. PMID: 35927255.
7. Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness. 2026. PMID: 41655607.
8. Timmers S et al. Resveratrol and energy metabolism in obese humans. 2011. PMID: 22055504.

This article is informational and does not replace medical assessment. NAD+ precursors, concentrated polyphenols and fasting can have contraindications or interactions.